INTERCEPT PHARMACEUTICALS, INC. Annual Cost of Revenue in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from 2017 to 2022.
  • Intercept Pharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $197K, a 53.5% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending September 30, 2023 was $632K, a 27.6% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $984K, a 18.3% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Cost of Revenue for 2021 was $1.21M, a 48.8% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Cost of Revenue for 2020 was $2.35M, a 44.1% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $984K -$221K -18.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $1.21M -$1.15M -48.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $2.35M -$1.86M -44.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $4.21M +$1.69M +67.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $2.52M +$1.15M +83.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1.37M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.